论文部分内容阅读
目的:研究应用粒细胞集落刺激因子(G-CSF)动员内皮祖细胞(EPC)治疗心肌梗死(MI)后心力衰竭(心衰)患者心功能及心肌能量消耗的改变。方法:选取38例MI后心衰患者,入院后均接受MI后心衰的常规治疗(包括药物治疗和介入治疗),随机分成治疗组和对照组,治疗组除常规治疗外还给予EPC动员剂G-CSF(600μg/d)皮下注射,连续7 d。检测2组治疗前、治疗后第7天和第4个月血浆脑利钠钛(BNP)值及外周血EPC数量,治疗前、治疗后第2周和第4个月行心脏超声检测左室心功能指标:左室射血分数(LVEF)、短轴缩短率(FS)、收缩末期内径、左室壁厚度、左室舒张末期容积、每搏量、射血时间,应用相关公式计算心肌能量消耗(MEE)、左室收缩末圆周室壁应力(cESS)。结果:治疗组的EPC数量较对照组增加明显,尤其第7天增加有显著差异(P<0.01);2组患者血浆BNP值较治疗前均显著下降且恢复正常值(P<0.01);2组心功能指标及心肌能量消耗治疗后均有所好转(P<0.05),治疗组较对照组改善明显(P<0.05),尤以治疗组cESS、MEE第2周下降明显,差异有统计学意义(P<0.01);及治疗组LVEF、FS第4个月增加明显,差异有显著性(P<0.01)。结论:应用G-CSF动员EPC治疗MI后心衰患者,可有效改善心功能,减轻心室重构,降低心肌能量消耗。
Objective: To study the changes of cardiac function and myocardial energy expenditure in patients with heart failure (CHF) after mobilization of endothelial progenitor cells (EPCs) with granulocyte colony-stimulating factor (G-CSF) to treat myocardial infarction (MI) Methods: Thirty-eight MI patients with heart failure were enrolled. After admission, they received conventional therapy (including drug treatment and interventional therapy) of heart failure after MI and were randomly divided into treatment group and control group. In addition to conventional treatment, EPCs G-CSF (600 μg / d) was injected subcutaneously for 7 days. Plasma BNP and EPC counts of two groups were measured before treatment, 7 days and 4 months after treatment. Before the treatment, at the second week and the fourth month after treatment, the left ventricular Cardiac function indicators: left ventricular ejection fraction (LVEF), short axis shortening (FS), end-systolic diameter, left ventricular wall thickness, left ventricular end-diastolic volume, stroke volume, ejection time, Consumption (MEE), left ventricular end-systolic circumferential wall stress (cESS). Results: Compared with the control group, the number of EPC in the treatment group increased significantly (especially on the 7th day) (P <0.01). The plasma BNP levels in the two groups were significantly lower than those before treatment and returned to normal (P <0.01); 2 (P <0.05). The treatment group improved significantly compared with the control group (P <0.05), especially in the 2nd week of cESS and MEE in the treatment group, the difference was statistically significant (P <0.01). The LVEF and FS of the treatment group increased significantly at the 4th month, with a significant difference (P <0.01). Conclusion: G-CSF mobilization of EPCs in patients with CHF after heart failure can effectively improve cardiac function, reduce ventricular remodeling, and reduce myocardial energy expenditure.